Egypt Cardiovascular Market Analysis


  • Type: Therapeutics Area
  • Published : June 2021
  • Region: Africa
  • Country: Egypt
  • Report ID : 4767

  • Format: PPT, PDF

Egypt Cardiovascular Diseases Drug Market: Segmentation by Drug Class (Antihypertensive, Antihyperlipidemic, Anticoagulants, and Antiplatelet Drugs), Disease Indication (Hypertension, Hyperlipidaemia, Coronary Artery Disease, and Arrhythmia) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Growth, Trends, And Forecasts (2019 – 2028)

 Published Date: June, 2021

SKU: 4767 Categories: ,

Egypt’s Cardiovascular diseases drugs market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

In Egypt, cardiovascular disease (CVD) has been the leading cause of premature death since the 1990s. It is the most populous of the Middle East and North American countries and recent studies revealed higher CAD mortality rates in this region.  In 2017, CVD accounted for 46.2% of the overall mortality in Egypt. Given the aging of the population and the success in prolonging the survival of those with coronary events, heart failure (HF) poses an important and growing public health burden.

Recent studies expressed that ACS patients in Egypt are relatively young (mean age 57 years) compared with patients living in the West (mean age 66 years). In line with the Cardio Risk study done across Egypt, central obesity, diabetes, and hypertension were more prevalent in women with ACS and were acknowledged as major risk factors for ACS. With these statistics, the market for the disease is likely to grow in demand in the forecast period.

Market Drivers

Egypt’s epidemiological profile, characterized by a high chronic disease burden, will drive prescription medicine expenditure over the coming years. Rapid population growth and a gradually aging population represent potential for pharmaceutical firms to expand, with the emergence of diabetes, hypertension, and cardiovascular diseases driving the growth of higher value prescription medicines.

The disease burden of Cardiovascular has consistently topped the list of most death-causing diseases in Egypt and is likely to grow in the future. Ischemic heart disease has consistently remained on top of the table for Egypt and the deaths caused by it have seen a rise of 26.9% from 2009 to 2019. It is also the no. one cause for DALYs in Egypt. Mortality caused by Hypertensive heart diseases has seen a rise of 24.4.% from 2009 to 2019.

Further, data indicate that the elder population has a higher prevalence of CAD risk factors. Given that the geriatric population of Egypt is expected to expand by more than twice its present size, the risk of cardiovascular disease will also increase.  Such a rise in the burden of the disease will drive the cardiovascular disease drug market in Egypt.

Other initiatives such as 100 million healthy Lives, launched in Egypt will drive the NCD pharmaceuticals market due to increased awareness, diagnosis, and treatment among the population.

This indicates that the pharmaceutical market of Egypt is likely to encourage local players more than international penetration in the near future.

1. Cardiovascular Disease Drugs Market Overview…………………………..
A. Market Size
2. Market Growth Drivers……………………………………………………….
A. Rise in Prevalence of Cardiovascular Disease in Egypt
B. Rapidly Rising Elderly Population in Egypt
C. Major Initiatives by Govt. to Tackle NCD Disease Burden
D. Increased Awareness Regarding Cardiovascular Health
3. Major Types of Cardiovascular Diseases
A. Arrhythmias
B. Aorta disease and Marfan syndrome
C. Congenital heart disease
D. Coronary artery disease
E. Deep vein thrombosis and pulmonary embolism
F. Heart attack
G. Heart failure
H. Heart muscle disease (cardiomyopathy)
I. Heart valve disease
J. Pericardial disease
K. Peripheral vascular disease
L. Rheumatic heart disease
M. Stroke
N. Vascular disease
4. Cardiovascular Disease Drugs Market Segmentation………………….
A. Drug Class
I. Antihypertensive
II. Antihyperlipidemic
III. Anticoagulants
IV. Antiplatelet Drugs
B. Disease Indication
I. Hypertension
II. Hyperlipidaemia
III. Coronary Artery Disease
IV. Arrhythmia
C. By Distribution Channel
I. Hospital Pharmacies
II. Online Pharmacies
III. Retail Pharmacies
5. Cardiovascular Disease Major Drugs Market Share…………………..
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. EIPICO. Company overview, Product & Services, Strategies & Financials
C. GSK Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………….
A. New Trends and Development of Cardiovascular disease drug market
B. Future Opportunities
10. Conclusion

By Drug class

The market for the treatment of cardiovascular disease has been segmented on types of drugs available for the diseases mainly Antihypertensive, Antihyperlipidemic, Anticoagulants, and antiplatelet drugs

By Disease Indication

On the basis of disease indication, the cardiovascular drugs market is segmented into Hypertension, Hyperlipidaemia, Coronary Artery Disease, and Arrhythmia

By Distribution Channel

By distribution channel, the market for cardiovascular drugs in Egypt can be segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies

Major Players

Egypt’s Cardiovascular diseases treatment market appears to be fragmented with the presence of several local and global companies including AstraZeneca, Novartis, GSK, Sanofi, Pharco, Amoun, EIPICO, Eva Pharma, Pfizer, Hikma, SEDICO.

AstraZeneca’s production in Egypt was previously contracted out to a local manufacturer. AstraZeneca has since built a pharmaceuticals production facility near Cairo, which produces a broad range of the company’s products including cardiovascular and cancer treatments. The decision by AstraZeneca to focus on three product lines in Egypt – cardiovascular, cancer and psychiatric drugs – follows local epidemiological trends

SEDICO’s product portfolio includes analgesics, antihistamines and nasal decongestants, antidepressants and cardiovascular drugs. As such, the company is well placed to continue taking advantage of the country’s disease profile and its growing population. SEDICO manufactures its own products and those under licence from various multinationals, including AstraZeneca UK, as well as other foreign players, such as Trenka (based in Austria).


Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements